Omeros Corporation (Nasdaq: OMER) today announced the availability on its website of materials accompanying two presentations ...
Terumo Corporation ( OTCPK:TRUMF) Q3 2025 Earnings Conference Call February 13, 2025 3:00 AM ET [Call Starts Abruptly] Thank you for your kind introduction. I’m Hagimoto, Terumo’s CFO. This ...
In summary, enalapril significantly mitigated multiple pathological markers associated with aging, including lipid droplets, amyloid, glycogen deposition, and fibrosis, in the brain, kidneys, liver, ...
Welcome to the Adaptive Biotechnologies fourth-quarter and full-year 2024 financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded. I ...
6don MSNOpinion
Pleas for mercy have turned into threats of suicide and the nurses are not prepared. “Legos?” they suggest to my son. All of ...
Crispr Therapeutics AG has revenue declines but holds strong financials. Promising Sickle Cell therapy & 2025 data readouts ...
Gustav Klimt attended discussions of scientific developments, like the microscope, which he incorporated into his work ...
Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...
The MAD cohort also saw adverse events such as hair loss and reductions in hemoglobin and neutrophil counts. These side ...
When prostate cancer patients need therapy to reduce male hormone levels, delivering some of the treatment via a patch on the skin may be just as effective as traditional means of administration with ...
Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...
Q4 2024 Earnings Call Transcript February 10, 2025 Operator: Greetings, and welcome to the Incyte Fourth Quarter 2024 and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results